10 | Bortezomib (Velcade)FDA Link
04/2022
-
12/2005 |
9 | Proteasome InhibitorsIBA
12/2020
-
06/2006 |
9 | Proteins (Proteins, Gene)FDA Link
12/2020
-
04/2011 |
7 | Arsenic Trioxide (Trisenox)FDA Link
01/2012
-
01/2002 |
6 | venetoclaxIBA
01/2021
-
12/2018 |
5 | Dexamethasone (Maxidex)FDA LinkGeneric
04/2022
-
06/2007 |
5 | Glutathione (Reduced Glutathione)IBA
05/2014
-
12/2002 |
4 | Immunoglobulins (Immunoglobulin)IBA
12/2020
-
05/2010 |
4 | ArsenicIBA
01/2016
-
01/2001 |
3 | Lenalidomide (CC 5013)FDA Link
04/2022
-
11/2019 |
3 | Phosphotransferases (Kinase)IBA
11/2019
-
06/2005 |
3 | darinaparsinIBA
01/2016
-
05/2009 |
2 | VaccinesIBA
09/2021
-
01/2019 |
2 | Proteasome Endopeptidase Complex (Proteasome)IBA
12/2020
-
08/2015 |
2 | 14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA
09/2017
-
01/2016 |
2 | Serine (L-Serine)FDA Link
09/2017
-
09/2016 |
2 | KetonesIBA
01/2017
-
01/2017 |
2 | acetoacetic acid (acetoacetate)IBA
01/2017
-
01/2017 |
2 | carfilzomibIBA
01/2016
-
05/2015 |
2 | Doxorubicin (Adriamycin)FDA LinkGeneric
05/2015
-
01/2012 |
2 | Arsenicals (Arsenic Compounds)IBA
05/2014
-
05/2009 |
2 | TransferasesIBA
02/2004
-
12/2003 |
2 | Ascorbic Acid (Vitamin C)FDA LinkGeneric
12/2002
-
01/2001 |
1 | Adrenergic Agents (Adrenergic Drugs)IBA
01/2022 |
1 | Immunoglobulin M (IgM)IBA
11/2021 |
1 | AntibodiesIBA
09/2021 |
1 | ImidesIBA
09/2021 |
1 | vendexIBA
01/2021 |
1 | Biomarkers (Surrogate Marker)IBA
01/2021 |
1 | RNA (Ribonucleic Acid)IBA
01/2021 |
1 | Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA
01/2021 |
1 | Oncogene Proteins (Oncogene Protein)IBA
01/2021 |
1 | ChromatinIBA
01/2021 |
1 | Hormones (Hormone)IBA
01/2020 |
1 | Docetaxel (Taxotere)FDA Link
01/2020 |
1 | daratumumabIBA
01/2019 |
1 | 2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2019 |
1 | Chimeric Antigen ReceptorsIBA
01/2019 |
1 | AZD5991IBA
12/2018 |
1 | lestaurtinibIBA
01/2018 |
1 | Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2018 |
1 | PlatinumIBA
01/2018 |
1 | Cisplatin (Platino)FDA LinkGeneric
01/2018 |
1 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2018 |
1 | 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
01/2017 |
1 | Hypolipidemic Agents (Antihyperlipidemics)IBA
01/2017 |
1 | Dietary Fats (Dietary Fat)IBA
01/2017 |
1 | DNA (Deoxyribonucleic Acid)IBA
01/2017 |
1 | EnzymesIBA
01/2017 |
1 | Protein Isoforms (Isoforms)IBA
01/2017 |
1 | Hydroxymethylglutaryl-CoA SynthaseIBA
01/2017 |
1 | Acetyl Coenzyme A (Acetyl-CoA)IBA
01/2017 |
1 | 5-carboxylcytosineIBA
01/2017 |
1 | dehydroacetic acid (DHAS)IBA
01/2017 |
1 | NucleotidesIBA
01/2017 |
1 | 3-hydroxy-3-methylglutaryl-coenzyme A lyase (HMG-CoA lyase)IBA
01/2017 |
1 | BDA-366IBA
05/2016 |
1 | ricolinostatIBA
05/2015 |
1 | Immunomodulating AgentsIBA
09/2014 |
1 | EicosanoidsIBA
01/2014 |
1 | TNF Receptor-Associated Factor 3IBA
01/2014 |
1 | Arachidonic Acid (Vitamin F)IBA
01/2014 |
1 | Cytochromes c (Cytochrome c)IBA
06/2012 |
1 | RMT5265IBA
06/2012 |
1 | Melphalan (Alkeran)FDA LinkGeneric
01/2012 |
1 | Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2011 |
1 | Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2011 |
1 | CCR2 ReceptorsIBA
09/2011 |
1 | Messenger RNA (mRNA)IBA
06/2011 |
1 | IntegrinsIBA
06/2011 |
1 | Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA
05/2010 |